Cayman Court Appoints Provisional Liquidators to New Horizon Health Limited

Exploring Offshore Litigation · Sep 15, 2025 · 4m

The Company operates predominantly in China. It is in the business of assisting with screening and diagnosis of cancers of various kinds and has developed products to provide early screening, particularly for bowel cancer. It appeared to have been successful for a number of years. However, in 2023, complaints were made by a third party that the Company's sales figures did not appear to be justifiable. This triggered an internal investigation which raised questions about the reliability of sales data within the Company and some suggestions that the Company's revenue had been overstated. Due to…